Brain, behavior, and immunity · 2009
Nuclear translocation and calpain-dependent reduction of Bcl-2 after neonatal cerebral hypoxia-ischemia.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhu Changlian, Hallin Ulrika, Ozaki Yasuhiko, Grandér Rita, Gatzinsky Kliment, Bahr Ben A, Karlsson Jan-Olof, Shibasaki Futoshi, Hagberg Henrik, Blomgren Klas
Аннотация
Apoptosis-related mechanisms are important in the pathophysiology of hypoxic-ischemic injury in the neonatal brain. Caspases are the major executioners of apoptosis, but there are a number of upstream players that influence the cell death pathways. The Bcl-2 family proteins are important modulators of mitochondrial permeability, working either to promote or prevent apoptosis. In this study we focused on the anti-apoptotic Bcl-2 protein after neonatal cerebral hypoxia-ischemia (HI) in 8-day-old rats. Bcl-2 translocated to nuclei and accumulated there over the first 24h of reperfusion after HI, as judged by immunohistochemistry and immuno-electron microscopy. We also found that the total level of Bcl-2 decreased after HI in vivo and after ionophore challenge in cultured human neuroblastoma (IMR-32) cells in vitro. Furthermore, the Bcl-2 reduction was calpain-dependent, because it could be prevented by the calpain inhibitor CX295 both in vivo and in vitro, suggesting cross-talk between excitotoxic and apoptotic mechanisms.
Предметные рубрики MeSH
Active Transport, Cell NucleusAnalysis of VarianceAnimalsAnimals, NewbornApoptosisBlotting, WesternCalpainCell Line, TumorCell NucleusCells, CulturedFemaleHumansHypoxia-Ischemia, BrainImmunohistochemistryMaleMicroscopy, ImmunoelectronProto-Oncogene Proteins c-bcl-2RatsRats, Wistarbcl-2-Associated X Protein